Biotalys N.V.
BTLS.BR · BRU
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.21 | 0.59 | -0.29 | -0.23 |
| FCF Yield | -11.83% | -12.72% | -9.90% | -8.34% |
| EV / EBITDA | -7.32 | -6.76 | -8.71 | -10.02 |
| Quality | ||||
| ROIC | -40.84% | -64.92% | -50.30% | -27.31% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.94 | 0.88 | 0.89 | 0.93 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | 31.75% | 9.90% | -15.00% | -34.33% |
| Safety | ||||
| Net Debt / EBITDA | 1.44 | 0.79 | 1.32 | 2.92 |
| Interest Coverage | 0.00 | 0.00 | -91.22 | -73.49 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |